We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Information and guidance on a range of medical devices for users and patients.
Information for patients, public and health care professionals.
The review of the safety of isotretinoin has concluded.
Guidance on how to license electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in the UK.
Directory of current ICH Guidelines which have been implemented by the Medicines and Healthcare products Regulatory Agency.
A document for patients explaining how the highest risk patient groups eligible for new coronavirus treatments will be identified.
Provisional information about the pre and post-operative health status of patients undergoing common elective procedures (hip and knee replacements, varicose vein and groin hernia).
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Provisional information about the pre and post operative health status of patients undergoing common elective procedures (hip and knee replacements, varicose vein and groin hernia).
Practical advice for clinicians caring for immunocompromised persons who wish to travel or who have travelled to Zika-affected countries or areas.
Privacy notice for patients participating in surgical site infection surveillance.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).